Company / Financials
Biogen Financials
FY2009-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$9.9B
FY2025 · +2.2% YoY
Net Income
$1.3B
FY2025 · -20.8% YoY
Profit Margin
13.1%
FY2025 · net income / revenue
ROE
7.1%
FY2025 · return on equity
Total Assets
$29.4B
FY2025
Total Debt
$6.3B
0.34x debt/equity
Equity
$18.3B
FY2025
ROA
4.4%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$9.9B+2.2% YoYNet Income HistoryProfit after all expenses and taxes$1.3B-20.8% YoYGross Profit HistoryRevenue minus cost of goods sold-Cost of Revenue HistoryDirect costs of producing goods and services sold$2.4B+4.1% YoYOperating Income HistoryProfit from core business operations before interest and taxes-SG&A Expense HistorySelling, general, and administrative expenses$2.4B+1.2% YoYR&D Expense HistoryResearch and development spending$1.8B-10.2% YoYInterest Expense HistoryCost of borrowing and debt obligations$267.5M+6.9% YoYIncome Tax HistoryTotal income tax expense$263.6M-3.7% YoYEPS (Basic) HistoryBasic earnings per share$8.02-61.7% YoY